Acrux Ltd

ACR

Company Profile

  • Business description

    Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

  • Contact

    103-113 Stanley Street
    West Melbourne
    MelbourneVIC3003
    AUS

    T: +61 383790100

    E: [email protected]

    https://www.acrux.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    36

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,741.9026.70-0.30%
CAC 407,778.3411.93-0.15%
DAX 4024,233.8889.70-0.37%
Dow JONES (US)42,319.74108.00-0.25%
FTSE 1008,829.0017.960.20%
HKSE23,822.4484.53-0.35%
NASDAQ19,298.45162.04-0.83%
Nikkei 22537,741.61187.120.50%
NZX 50 Index12,563.4813.67-0.11%
S&P 5005,939.3031.51-0.53%
S&P/ASX 2008,515.7023.20-0.27%
SSE Composite Index3,385.361.260.04%

Market Movers